Clinical Trials Browser

Phase 3 × Metastatic Castration-sensitive Prostate Cancer × 30 days × Clear all

NCT04497844 2026-05-11

AMPLITUDE

Phase 3 Active not recruiting

696 enrolled 15 charts 1 FDA

Metastatic Castration-sensitive Prostate Cancer